Scarica l'app Stockscreener
4.32
0.47%
0.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OM Giù?
Forum
Previsione
Precedente Chiudi:
$4.30
Aprire:
$4.35
Volume 24 ore:
691
Relative Volume:
0.00
Capitalizzazione di mercato:
$81.77M
Reddito:
$117.59M
Utile/perdita netta:
$-74.85M
Rapporto P/E:
-1.0347
EPS:
-4.175
Flusso di cassa netto:
$-34.25M
1 W Prestazione:
-4.21%
1M Prestazione:
+4.85%
6M Prestazione:
+22.38%
1 anno Prestazione:
-68.40%
Intervallo 1D:
$4.35
$4.4145
Intervallo di 1 settimana:
$4.16
$4.54
Portata 52W:
$3.00
$16.16
Outset Medical Inc Stock (OM) Company Profile
Nome
Outset Medical Inc
Settore
Industria
Telefono
669-231-8200
Indirizzo
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
4.35 | 80.83M | 117.59M | -74.85M | -34.25M | -4.175 |
ABT
Abbott Laboratories
|
114.75 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.92 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.36 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.62 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.54 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Iniziato | BTIG Research | Buy |
| 2024-04-05 | Aggiornamento | CL King | Neutral → Buy |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-17 | Iniziato | CL King | Neutral |
| 2022-11-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-07-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Iniziato | Cowen | Outperform |
| 2021-04-19 | Iniziato | Wells Fargo | Overweight |
| 2020-12-16 | Iniziato | Oppenheimer | Perform |
| 2020-10-12 | Iniziato | Barclays | Overweight |
| 2020-10-12 | Iniziato | BofA Securities | Buy |
| 2020-10-12 | Iniziato | Goldman | Buy |
| 2020-10-12 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-10-12 | Iniziato | Stifel | Buy |
Mostra tutto
Outset Medical Inc Borsa (OM) Ultime notizie
Outset Medical (OM) Q2 2026 Earnings Call Transcript - AOL.com
Outset (OM) Results at a Glance: Reported EPS Misses Expectations at the Close; Session Move: The Stock Ends Down 1.05% in the Latest ReadingEarnings Manipulation Risk - Vinanet
Outset Medical CEO Leslie Trigg sells $15,088 in shares By Investing.com - Investing.com Australia
Outset Medical CEO Leslie Trigg sells $15,088 in shares - Investing.com
Leslie Trigg Sells 3,437 Shares of Outset Medical (NASDAQ:OM) Stock - MarketBeat
Outset Medical general counsel sells $11,554 in stock By Investing.com - Investing.com Canada
Outset Medical general counsel sells $11,554 in stock - Investing.com
Outset Medical CFO Renee Gaeta sells $19,943 in stock By Investing.com - Investing.com Australia
Outset Medical CFO Renee Gaeta sells $19,943 in stock - Investing.com
Outset Medical (NASDAQ:OM) CFO Renee Gaeta Sells 4,543 Shares of Stock - MarketBeat
Outset Medical (OM) counsel sells shares to cover taxes - Stock Titan
OM Q2 2026 Earnings: EPS Misses Estimates as Loss Per Share WidensEarnings Risk Report - Vinanet
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock - Yahoo Finance
Outset Medical (NASDAQ:OM) Raised to Hold at Wall Street Zen - MarketBeat
OM (OM) insider schedules potential sale of 4,422 shares after RSU vesting - Stock Titan
Outset Medical (OM) insider Leslie Trigg plans NASDAQ sale of 3,344 shares - Stock Titan
Outset Medical (OM) insider files to sell shares and settle RSUs - Stock Titan
OM Q2 2026 Earnings: Wider-than-Expected Loss Sends Shares Down 5.6%Earnings Miss Streak - Vinanet
OM Q2 2026 Earnings: Wider Loss Per Share Sends Stock Down 6.6%Earnings Per Share - Vinanet
Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Bank of America (OM) reports 3.5% beneficial stake in Outset Medical shares - Stock Titan
AQR Capital discloses 5.39% Outset Medical (OM) ownership in Schedule 13G - Stock Titan
RBC Capital Initiates Outset Medical(OM.US) With Hold Rating, Announces Target Price $7 - Moomoo
Outset Medical Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Outset Medical (NASDAQ:OM) Issues Quarterly Earnings Results - marketbeat.com
Outset Medical 2Q Rev $31.6M >OM - Moomoo
Is Outset Medical Inc (OM) Meeting Investor Expectations with Q2 - GuruFocus
OM Looks 24.4% Overvalued on GF Value™ - GuruFocus
OM Looks 24.4% Overvalued on GF Value™ as Market Prices in Growt - GuruFocus
Outset Medical Inc (OM) (Q2 2026) Earnings Call Highlights: Reve - GuruFocus
Outset Medical Q2 Earnings Call Highlights - MarketBeat
Outset Medical Inc (OM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Strategic HCA ... - Yahoo Finance
Outset Medical earnings missed by $0.05, revenue topped estimates - Investing.com Canada
Outset Medical (OM) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Earnings call transcript: Outset Medical posts mixed Q2 2026 results, shares edge up - Investing.com
Outset Medical, Inc. Q2 2026: Revenue $31.6M, EPS $(0.97) — 10-Q Summary - TradingView
[10-Q] Outset Medical, Inc. Quarterly Earnings Report - Stock Titan
Outset Medical, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Outset Medical Inc Earnings Call Transcript - GuruFocus
Outset Medical Q2 adjusted loss per share narrows less than expected - TradingView
Outset Medical Reports Second Quarter 2026 Results - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Outset Medical reports Q2 revenue $31.6M, gross margin 42%, reiterates 2026 guidance - TradingView
BRIEF-Outset Medical Q2 Net Income USD -17.984 Million - TradingView
Outset Medical (OM) Rallies 1.95% as Shares Hold Above $4.96 SupportLong Setup Ideas - Vinanet
Earnings To Watch: Outset Medical Inc (OM) Q2 2026 -- GF Value S - GuruFocus
Earnings To Watch: Outset Medical Inc (OM) Q2 2026 -- GF Value Sees 12% Downside - Yahoo Finance
Outset Medical Market Sentiment - Benzinga España
Outset Medical, Inc. expected to post a loss of 72 cents a shareEarnings Preview - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Outset Medica - The National Law Review
Outset Medical Inc Azioni (OM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):